Medicines
Central Nervous System
Drugs used in parkinsonism and related disorders
Tafamidis meglumine (old)

Tafamidis meglumine (old)

Central Nervous System Drugs used in parkinsonism and related disorders BNF 0409030S0

Data updated April 2025 Download CSV

1items

Dispensed in April 2025

0items

Rolling 12 months

£712

Net ingredient cost · April 2025

Figure 1. Tafamidis meglumine (old): national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to April 2025

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/tafamidis-meglumine-old-0409030s0" width="100%" height="280" style="border:0" loading="lazy" title="Tafamidis meglumine (old): NHS prescribing in England — PharmaInsight"></iframe>
<p style="font-size:13px;margin-top:4px">Chart: <a href="https://pharmainsight.co.uk/medicines/tafamidis-meglumine-old-0409030s0">PharmaInsight</a> · Data: NHSBSA Prescription Cost Analysis</p>

Free to reuse with the credit line above.

At a glance

Therapeutic class Drugs used in parkinsonism and related disorders
Presentations 1 shown
Average cost / item £712.33

What this is

Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Where Tafamidis meglumine (old) is dispensed

The regions and dispensing practices with the highest Tafamidis meglumine (old) volumes.

Top regions

NHS Greater Manchester Integrated Care Board 1

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Tafamidis meglumine (old) with

Other medicines in the same BNF section, by prescribing volume.

Tafamidis meglumine (old) vs Co-careldopa (Carbidopa/levodopa) Tafamidis meglumine (old) vs Co-beneldopa (Benserazide/levodopa) Tafamidis meglumine (old) vs Procyclidine hydrochloride Tafamidis meglumine (old) vs Ropinirole hydrochloride Tafamidis meglumine (old) vs Pramipexole

Download this data

The monthly series for Tafamidis meglumine (old) is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.